CIK 0000875045 · Large accelerated filer
BIOGEN INC.
Sign in to watch- Ticker
- BIIB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330112644
- Phone
- 6176792000
- Business address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-07 | ALEXANDER SUSAN H EVP Chief Legal Officer | Option exercise · Restricted Stock Unit | −1,940 | 3,880 | ||
| 2025-02-06 | Viehbacher Christopher President and CEO | Grant or award · Restricted Stock Unit | +46,360 | 46,360 | ||
| 2025-02-06 | Grogan Jane Head of Research | Grant or award · Restricted Stock Unit | +5,620 | 5,620 | ||
| 2025-02-06 | Keeney Adam Head of Corporate Development | Grant or award · Restricted Stock Unit | +9,835 | 9,835 | ||
| 2025-02-06 | Izzar Rachid Head of Global Product Strat. | Grant or award · Restricted Stock Unit | +9,130 | 9,130 | ||
| 2025-02-06 | Kramer Robin Chief Accounting Officer | Grant or award · Restricted Stock Unit | +10,535 | 10,535 | ||
| 2025-02-06 | Murphy Nicole Head of Pharm Ops and Tech | Grant or award · Restricted Stock Unit | +14,050 | 14,050 | ||
| 2025-02-06 | Singhal Priya Head of Development | Grant or award · Restricted Stock Unit | +14,050 | 14,050 | ||
| 2025-02-06 | Gregory Ginger EVP, Human Resources | Grant or award · Restricted Stock Unit | +11,240 | 11,240 | ||
| 2025-02-06 | ALEXANDER SUSAN H EVP Chief Legal Officer | Grant or award · Restricted Stock Unit | +14,750 | 14,750 | ||
| 2025-01-31 | Singhal Priya Head of Development | Option exercise | +1,828 | 7,254.48 | ||
| 2025-01-31 | Singhal Priya Head of Development | Shares withheld for taxes | −578 | $143.93 | $83K | 6,676.48 |
| 2025-01-31 | Singhal Priya Head of Development | Option exercise · Restricted Stock Unit | −1,828 | 1,829 | ||
| 2024-12-09 | Singhal Priya Head of Development | Sale 10b5-1 | −110 | $157.21 | $17K | 5,426.48 |
| 2024-12-06 | Singhal Priya Head of Development | Option exercise 10b5-1 | +426 | 5,742.48 | ||
| 2024-12-06 | Singhal Priya Head of Development | Shares withheld for taxes 10b5-1 | −206 | $157.78 | $33K | 5,536.48 |
| 2024-12-06 | Singhal Priya Head of Development | Option exercise · Restricted Stock Unit 10b5-1 | −426 | 0 | ||
| 2024-12-06 | Kramer Robin Chief Accounting Officer | Option exercise | +351 | 6,577.75 | ||
| 2024-12-06 | Kramer Robin Chief Accounting Officer | Shares withheld for taxes | −170 | $157.78 | $27K | 6,407.75 |
| 2024-12-06 | Kramer Robin Chief Accounting Officer | Option exercise · Restricted Stock Unit | −351 | 0 |
Page 12 of 29 · 579 trades